149 related articles for article (PubMed ID: 38459103)
21. Characterization of Second Primary Malignancies in Mucosa-Associated Lymphoid Tissue Lymphomas: A SEER Database Interrogation.
Timilsina S; Damato A; Budhathoki N; Grossbard ML; Braunstein M
Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):76-81. PubMed ID: 34493476
[TBL] [Abstract][Full Text] [Related]
22. The Impact of Radiotherapy on the Incidence of Secondary Malignancies: A Pan-Cancer Study in the US SEER Cancer Registries.
Li W; Xiao H; Xu X; Zhang Y
Curr Oncol; 2021 Jan; 28(1):301-316. PubMed ID: 33435562
[TBL] [Abstract][Full Text] [Related]
23. Better Prognosis of Gastric Neuroendocrine Carcinoma Than Gastric Adenocarcinoma among Whites in the United States: A Propensity Score Matching Analysis Based on SEER.
Li Z; Ren H; Zhao L; Zhang X; Wang T; Sun C; Niu P; Wang W; Fei H; Guo C; Chen Y; Zhao D
Curr Oncol; 2022 Jul; 29(7):4879-4892. PubMed ID: 35877247
[TBL] [Abstract][Full Text] [Related]
24. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
25. Risk of second primary malignancies associated with radiotherapy in prostate cancer patients: competing risk analysis.
Wu Y; Li Y; Han C; Chong Y; Kang K; Liu Z; Zhang F
Future Oncol; 2022 Feb; 18(4):445-455. PubMed ID: 35018785
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics and overall survival nomogram of second primary malignancies after prostate cancer, a SEER population-based study.
Liu Y; Zhang P; Zhang Y; Zheng L; Xu W; Hou D; Kang Z
Sci Rep; 2021 Jan; 11(1):1293. PubMed ID: 33446816
[TBL] [Abstract][Full Text] [Related]
27. Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States.
Adjei Boakye E; Buchanan P; Hinyard L; Osazuwa-Peters N; Simpson MC; Schootman M; Piccirillo JF
Int J Cancer; 2019 Jul; 145(1):143-153. PubMed ID: 30613963
[TBL] [Abstract][Full Text] [Related]
28. Survival disparities for second primary malignancies diagnosed among childhood cancer survivors: A population-based assessment.
Brown AL; Arroyo VM; Agrusa JE; Scheurer ME; Gramatges MM; Lupo PJ
Cancer; 2019 Oct; 125(20):3623-3630. PubMed ID: 31251393
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for metachronous gastric carcinoma development after endoscopic resection of gastric dysplasia: Retrospective, single-center study.
Moon HS; Yun GY; Kim JS; Eun HS; Kang SH; Sung JK; Jeong HY; Song KS
World J Gastroenterol; 2017 Jun; 23(24):4407-4415. PubMed ID: 28706423
[TBL] [Abstract][Full Text] [Related]
30. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M
JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850
[TBL] [Abstract][Full Text] [Related]
31. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.
Iyer NG; Morris LG; Tuttle RM; Shaha AR; Ganly I
Cancer; 2011 Oct; 117(19):4439-46. PubMed ID: 21432843
[TBL] [Abstract][Full Text] [Related]
32. Risk of second primary malignancies of adolescent and young adult patients with germ cell cancer: A US population-based analysis.
Jiang S; Jiang H; Sun L; Luo Z
Curr Probl Cancer; 2021 Apr; 45(2):100641. PubMed ID: 32928566
[TBL] [Abstract][Full Text] [Related]
33. Risk and subtypes of secondary primary malignancies in diffuse large B-cell lymphoma survivors change over time based on stage at diagnosis.
Major A; Smith DE; Ghosh D; Rabinovitch R; Kamdar M
Cancer; 2020 Jan; 126(1):189-201. PubMed ID: 31509235
[TBL] [Abstract][Full Text] [Related]
34. Second primary malignancies in cervical cancer and endometrial cancer survivors: a population-based analysis.
Huang K; Xu L; Jia M; Liu W; Wang S; Han J; Li Y; Song Q; Fu Z
Aging (Albany NY); 2022 May; 14(9):3836-3855. PubMed ID: 35507749
[TBL] [Abstract][Full Text] [Related]
35. Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study.
Zhou B; Zang R; Song P; Zhang M; Bie F; Bai G; Li Y; Huai Q; Han Y; Gao S
J Transl Med; 2023 Jan; 21(1):10. PubMed ID: 36624443
[TBL] [Abstract][Full Text] [Related]
36. Standardized Incidence Rate, Risk and Survival Outcomes of Second Primary Malignancy Among Renal Cell Carcinoma Survivors: A Nested Case-Control Study.
Wang Z; Yin Y; Wang J; Zhu Y; Li X; Zeng X
Front Oncol; 2021; 11():716741. PubMed ID: 34395291
[TBL] [Abstract][Full Text] [Related]
37. Correlation between lymphoma and second primary malignant tumor.
Liu L; Zhang Q; Chen B
Medicine (Baltimore); 2023 May; 102(19):e33712. PubMed ID: 37171326
[TBL] [Abstract][Full Text] [Related]
38. Second primary malignancy risk among patients with gastric cancer: a nationwide population-based study in Taiwan.
Chen SC; Liu CJ; Hu YW; Yeh CM; Hu LY; Wang YP; Hung YP; Tzeng CH; Chiou TJ; Chen TJ; Teng CJ
Gastric Cancer; 2016 Apr; 19(2):490-497. PubMed ID: 25772342
[TBL] [Abstract][Full Text] [Related]
39. Risk of second primary malignancy in adults with pulmonary high-grade neuroendocrine carcinoma (HGNEC).
Wu X; Zhang X; Tao L; Chen P
BMC Cancer; 2020 Aug; 20(1):719. PubMed ID: 32746796
[TBL] [Abstract][Full Text] [Related]
40. Second Primary Malignancy in Bladder Carcinoma - A Population-based Study.
Khanal A; Budhathoki N; Singh VP; Shah BK
Anticancer Res; 2017 Apr; 37(4):2033-2036. PubMed ID: 28373478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]